P1169: COMPARISON OF REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA TREATED WITH EPCORITAMAB VS CHEMOIMMUNOTHERAPY

• Andrew Ip,
• Allison Rosenthal,
• Alex Mutebi,
• Tongsheng Wang,
• Monika Jun,
• Anthony Wang,
• Junhua Yu,
• Samantha Brodkin,
• Mariana Sacchi,
• Anupama Kalsekar,
• Javier Munoz

Affiliations

Andrew Ip

1 Hackensack University Medical Center, Hackensack, United States

Allison Rosenthal

2 Mayo Clinic, Phoenix, United States

Alex Mutebi

3 Genmab US, Inc., Princeton, United States

Tongsheng Wang

3 Genmab US, Inc., Princeton, United States

Monika Jun

3 Genmab US, Inc., Princeton, United States

Anthony Wang

4 AbbVie, Inc, North Chicago, United States

Junhua Yu

4 AbbVie, Inc, North Chicago, United States

Samantha Brodkin

3 Genmab US, Inc., Princeton, United States

Mariana Sacchi

3 Genmab US, Inc., Princeton, United States

Anupama Kalsekar

3 Genmab US, Inc., Princeton, United States

Javier Munoz

2 Mayo Clinic, Phoenix, United States